RARA CRAFT DATABASE for FDA Medical Devices
510(k)K190412

FDA DEVICE FACTS

CLUNGENE Multi-Drug Test Dip Card, CLUNGENE Multi-Drug Test Easy Cup

Hangzhou Clongene Biotech Co., Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMarch 21, 2019PRODUCT CODENGL

Indications for use

CLUNGENE® Multi-Drug Test Dip Card is competitive binding, lateral flow immunochromatographic assay for qualitative and simultaneous detection of Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Opiates Oxycodone, Secobarbital, Methadone, Buprenorphine, Phencyclidine, Methylenedioxymethamphetamine, Tricyclic Antidepressants, EDDP and Propoxyphene in human urine at the cutoff concentrations of: Drug Calibrator Cut-off Amphetamine d-Amphetamine 1000 ng/mL Secobarbital Secobarbital 300 ng/mL Oxazepam Oxazepam 300 ng/mL Cocaine Benzoylecgonine 300 ng/mL Methamphetamine d-Methamphetamine 1000 ng/mL Opiates Morphine 2000 ng/mL Methadone Methadone 300 ng/mL Oxycodone Oxycodone 100 ng/mL Marijuana 11-Nor-△9-Tetrahydrocannabinol-9 COOH 50 ng/mL Buprenorphine Buprenorphine 10 ng/mL Methylenedioxymethamphetamine D,L-Methylenedioxymethamphetamine 500 ng/mL Phencyclidine Phencyclidine 25 ng/mL Tricyclic Antidepressants Nortriptyline 1000 ng/mL EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) 300 ng/mL Propoxyphene d-Propoxyphene 300 ng/mL Configuration of the CLUNGENE® Multi-Drug Test Dip Card can consist of any combination of the above listed drug analytes. The test may yield positive results for the prescription drugs Buprenorphine, Oxazepam, Secobarbital, Nortriptyline, Propoxyphene and Oxycodone when taken at or above prescribed doses. It is not intended to distinguish between prescription use or abuse of these drugs. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive. The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS or LC/MS is the preferred confirmatory method. For in vitro diagnostic use only. CLUNGENE® Multi-Drug Test Easy Cup is competitive binding, lateral flow immunochromatographic assay for qualitative and simultaneous detection of Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Opiates, Oxycodone, Secobarbital, Methadone, Buprenorphine, Phencyclidine, Methylenedioxymethamphetamine, Tricyclic Antidepressants, EDDP and Propoxyphene in human urine at the cutoff concentrations of: Drug Calibrator Cut-off Amphetamine d-Amphetamine 1000 ng/mL Secobarbital Secobarbital 300 ng/mL Oxazepam Oxazepam 300 ng/mL Cocaine Benzoylecgonine 300 ng/mL Methamphetamine d-Methamphetamine 1000 ng/mL Opiates Morphine 2000 ng/mL Methadone Methadone 300 ng/mL Oxycodone Oxycodone 100 ng/mL Marijuana 11-Nor-△9-Tetrahydrocannabinol-9 COOH 50 ng/mL Buprenorphine Buprenorphine 10 ng/mL Methylenedioxymethamphetamine D,L-Methylenedioxymethamphetamine 500 ng/mL Phencyclidine Phencyclidine 25 ng/mL Tricyclic Antidepressants Nortriptyline 1000 ng/mL EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) 300 ng/mL Propoxyphene d-Propoxyphene 300 ng/mL Configuration of the CLUNGENE® Multi-Drug Test Easy Cup can consist of any combination of the above listed drug analytes. The test may yield positive results for the prescription drugs Buprenorphine, Oxazepam, Secobarbital, Nortriptyline, Propoxyphene and Oxycodone when taken at or above prescribed doses. It is not intended to distinguish between prescription use or abuse of these drugs. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive. The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS or LC/MS is the preferred confirmatory method. For in vitro diagnostic use only.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 25, 2026